CAS: 153804-05-8 - 2-propyl-3-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-5,6,7,8-tetrahydrocyclohepta[d]imidazol-4(3H)-one
Formel:C25H26N6O
InChl:InChI=1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4,8-9,12-15H,2,5-7,10-11,16H2,1H3,(H,27,28,29,30)
InChI Key:InChIKey=KCTFTBCZZUBAKN-UHFFFAOYSA-N
SMILES:O=C1C2=C(N=C(N2CC=3C=CC(=CC3)C=4C=CC=CC4C5=NN=NN5)CCC)CCCC1
- Synonyme:
- 153804-05-8
- 4(3H)-Cycloheptimidazolone, 5,6,7,8-tetrahydro-2-propyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
- 4(3H)-Cycloheptimidazolone, 5,6,7,8-tetrahydro-2-propyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
- 5,6,7,8-Tetrahydro-2-propyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-4(3H)-cycloheptimidazolone
- Fw 7203
- Kd 3-671
- Kt 3-671
- Kt 3671
- Pratosartan
- Pratosartan (JAN)
- Mehr Synonyme anzeigen
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Pratosartan REF: 3D-DGA80405CAS: 153804-05-8 | Min. 95% | Nachfragen | Di 21 Jan 25 | |
Pratosartan REF: TM-T16573CAS: 153804-05-8 | 98% | 907,00 €~2.337,00 € | Di 28 Jan 25 |
Pratosartan
Ref: 3D-DGA80405
1mg | Nachfragen | ||
5mg | Nachfragen | ||
10mg | Nachfragen |
Pratosartan
Ref: TM-T16573
25mg | 1.410,00 € | ||
50mg | 1.851,00 € | ||
100mg | 2.337,00 € |